ContractopenPA
TO DEVELOP AN ORALLY AVAILABLE SMALL MOLECULE ANTIVIRAL DRUG, WITH TREATMENT OF YELLOW FEVER VIRUS INFECTION AS THE PRIMARY INDICATION.
National Institutes of HealthDescription
TO DEVELOP AN ORALLY AVAILABLE SMALL MOLECULE ANTIVIRAL DRUG, WITH TREATMENT OF YELLOW FEVER VIRUS INFECTION AS THE PRIMARY INDICATION. Recipient: BARUCH S. BLUMBERG INSTITUTE Award Amount: $12.48M
Requirements
Source: USASpending.gov
Interested in this contract?
Sign up to get match scores, track opportunities, and manage proposals with AI-powered tools.
Contract Details
Value Range
Up to $12,480,000
Deadline
December 31, 2026
Geographic Scope
PA
Status
open
External Links
View Original ListingSee how well this contract matches your organization.
Get Your Match Score